BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Nordic AML Group - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nordic AML Group
X-ORIGINAL-URL:https://www.namlg.org
X-WR-CALDESC:Events for Nordic AML Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20241121T000000
DTEND;TZID=Europe/Paris:20241121T130000
DTSTAMP:20260526T063959
CREATED:20241024T062828Z
LAST-MODIFIED:20241024T062828Z
UID:10000019-1732147200-1732194000@www.namlg.org
SUMMARY:mIDH1-mutated AML: ivosidenib in clinical practice
DESCRIPTION:This Servier arranged webinar is for hematologists. The agenda for the webinar is: \n12:00-12:05 – Introduction by Erik Holgén\, Product Manager\, Servier \n12:05-12:30 – Prof. Dr. Michael Heuser – Will present the AGILE study and the clinical implications of the study results. \n12:30-12:45 – Docent Vladimir Lazarevic – Focusing on treatment of mIDH1 AML patients in the future \n12:45-13:00 – Questions & Answers \n——————- \nUnable to attend at this time? Register anyway to receive the recording afterwards. \nClick here to register
URL:https://www.namlg.org/event/midh1-mutated-aml-ivosidenib-in-clinical-practice/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20241121T120000
DTEND;TZID=Europe/Paris:20241121T170000
DTSTAMP:20260526T063959
CREATED:20241029T114558Z
LAST-MODIFIED:20241029T114558Z
UID:10000020-1732190400-1732208400@www.namlg.org
SUMMARY:MNSCT 2024 Meeting
DESCRIPTION:MNSCT 2024 Meeting  \nDate: 21 November 2024 \nVenue: Grand Hotel\, Lund\, Sweden or online \nRegistration: https://mkon.nu/mnsct_2024/registration \nProgram \n12:00-12:55   Lunch\, registration starts at 11.45 \n13:00-13:05   Welcome/Introduction  (Assoc. Prof. Andreas Björklund\, Stockholm\, Assoc. Prof. Jörg Cammenga\, Lund) \nSession 1:             \n13:05-13:45   Prof. Dr. Thomas Schröder\, University Hospital Essen\, Essen Germany — “Pharmacological preemptive and prophylactic approaches to prevent/treat relapse of   myeloid neoplasms after allo SCT” \n13:40-14:20  Assoc. Professor Dr. Luca Vago\, Milan\, Italy — “Mechanisms of immune escape after allogeneic stem cell transplantation” \n14:20-14:30   Coffee break \nSession 2:              \n14:30-15:10   Ass. Professor Dr. A\, Mishra\, MD (Tampa\, Florida) — “Targeted agents post- allo HSCT based on mutational status” \n15:15-15:55  Ass. Professor Dr. Jacqueline S. Garcia\, MD  (Harvard Medical School\, Dana-Farber Cancer Institute) — “Post transplant maintenance: Finding the sweet spot” \n16:00-16:55  Plenary discussion (all speakers (virtual/local) + moderators) \n16:55-17:00  Closing remarks
URL:https://www.namlg.org/event/mnsct-2024-meeting/
END:VEVENT
END:VCALENDAR